Protective effect of human ulinastatin against gentamicin-intiuced acute renal failure in rats

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 1, 1996, Pages 104-111

  Nakakuki, Masanori ^a   Yamasaki, Fumiaki ^a   Shinkawa, Tomoaki ^a   Kudo, Mami ^a   Watanabe, Mitsutoshi ^a   Mizota, Masahiro ^a  

^a MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

Gentamicin; Lysosome; Nephrotoxicity; Ulinastatin

Indexed keywords

GENTAMICIN; MIRACRID; N ACETYL BETA GLUCOSAMINIDASE; OROSOMUCOID; ULINASTATIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CREATINE; GENTAMICINS; GLYCOPROTEINS; HUMANS; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRYPSIN INHIBITORS;

EID: 0029873803     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y95-232     Document Type: Article

References (34)

1. Aroor, A.R., and Pattabiraman, T.N. 1979. Serum and urinary protease inhibitors in renal disorders. Indian J. Med. Res. 69: 798-803.
2. Balduyck, M., Davril, M., Mizon, C., Smyrlaki, M., Hayen, A., and Mizon, J. 1985. Human urinary proteinase inhibitors: inhibitory properties and interaction with bovine trypsin. Biol. Chem. Hoppe-Seyler, 366: 9-14.
3. Balduyck, M., Mizon, C., Loutfi, H., Richet, C., Roussel, R., and Mizon, J. 1986. The major human urinary trypsin inhibitor is a proteoglycan. Eur. J. Biochem. 158: 417-422.
4. Baylis, C., Rennke, H.R., and Brenner, B.M. 1977. Mechanisms of the defect in glomerular ultrafiltration associated with gentamicin administration. Kidney Int. 12: 344-353.
5. Beauchamp, D., Laurent, G., Maldague, G., Abid, P., Kishore, S., and Tulkens, B.K. 1986. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid. J. Pharmacol. Exp. Ther. 159: 919-925.
6. Coimbra, T.M., and Lachat, J. 1988. Analysis of urinary albumin excretion in gentamicin-treated rats. Nephron, 49: 154-159.
7. De Broe, M.E., Paulus, G.J., Verpooten, G.A., Roels, F., Buyssens, N., Wedeen, R., Van Hoof, F., and Tulkens, P. 1984. Early effects of gentamicin, tobramycin and amikacin on the human kidney. Kidney Int. 25: 643-652.
8. De Rougemont, D., Oeschger, A., Konrad, L., Thiel, G., Torhorst, J., Wenk, M., Wunderlich, P., and Brunner, F.P. 1981. Gentamicin-induced acute renal failure in the rat: effect of dehydration, DOCA-saline and furosemide. Nephron, 29: 176-184.
9. Haruuchi, T., and Yoshizaki, T. 1990. A method of determining urinary enzyme activities as nephrotoxic indicators in rats. Jpn. J. Pharmacol. 54: 205-215.
10. Higuchi, C. 1989. Pathophysiological mechanism of ischemic acute renal failure: protective effect of coenzyme Q10, Ca channel blocker, superoxide dismutase and protease inhibitor against ischemic acute renal failure. Jpn. J. Nephrol. 31: 15-24.
11. Hostetter, T.H., and Brenner, B.M. 1988. Renal circulatory and nephron function in experimental acute renal failure. In Acute renal failure. 2nd ed. Edited by B.M. Brenner and J.M. Lazarus. Churchill Livingstone, New York. pp. 67-89.
12. Houghton, D.C., Hartnell, M., Campbell-Boswell, M., Porter, G., and Bennett, W. 1976. Light and electron microscopic analysis of gentamicin nephrotoxicity in rats. Am. J. Pathol. 82: 589-612.
13. 1 cells treated with antimycin A, gentamycin and cisplatin. Nephron. In press.
14. Jönsson-Berling, B.-M., and Ohlsson, K. 1991. Distribution and elimination of intravenously injected urinary trypsin inhibitor. Scand. J. Clin. Lab. Invest 51: 549-557.
15. Kaloyanides, G.J., and Pastoriza-Munoz, E. 1980. Aminoglycoside nephrotoxicity. Kidney Int. 18: 571-582.
16. Klotman, P.E., and Yager, W.E. 1983. Reduction of renal blood flow and proximal bicarbonate reabsorption in rats by gentamicin. Kidney Int. 24: 638-643.
17. Kosek, J.C., Mazze, R.I., and Cousins, M.J. 1974. Nephrotoxicity of gentamicin. Lab. Invest. 30: 48-57.
18. 1-microglobulin: co-expression in liver with the light chain of inter-α-trypsin inhibitor. Biochim. Biophys. Acta, 1130: 63-67.
19. Miyahara, T. 1983. Effect of urinary trypsin inhibitor, MR-20, on hemorrhagic shock in dogs. Jpn. J. Anesthesiol. 32: 943-955.
20. Neugarten, J., Aynedjian, H.S., and Bank, N. 1983. Role of tubular obstruction in acute renal failure due to gentamicin administration. Kidney Int. 12: 344-353.
21. Nowak, S. 1968. The urinary trypsin inhibitors in some diseases. Enzymol. Biol. Clin. 9: 41-52.
22. Oda, T., Miyawaki, T., Sameshima, T., and Miyao, J. 1984. Anti-shock effects of urinary trypsin inhibitor, MR-20. Jpn. J. Anesthesiol. 33: 137-142.
23. Ohnishi, H., Kosuzume, H., Ashida, Y., Kato, K., Suzuki, Y., and Honjo, I. 1983. Therapeutic effects of human urinary trypsin inhibitor on acute experimental pancreatitis. Folia Pharmacol. Jpn. 81: 235-244.
24. Okano, S., Tagawa, M., Urakawa, N., and Ogawa, R. 1991. Effects of ulinastatin on endotoxin shock in dogs. Jpn. J. Anesthesiol. 41: 413-420.
25. Olbricht, C.J., Fink, M., and Gutjahr, E. 1991. Alterations in lysosomal enzymes of the proximal tubules in gentamicin nephrotoxicity. Kidney Int. 39: 639-646.
26. Powell, J.H., and Reidenberg, M.M. 1982. In vitro response of rat and human kidney lysosomes to aminoglycosides. Biochem. Pharmacol. 31: 3447-3453.
27. Regec, A.L., Trump, B.F., and Trifillis, A.L. 1988. Effect of gentamicin on the lysosomal system of cultured human proximal tubular cells. Biochem. Pharmacol. 37: 2527-2534.
28. Ruth, R.C., and Weglicki, W.B. 1978. The temperature-dependence of the loss of latency of lysosomal enzymes. Biochem. J. 172: 163-173.
29. Ruth, R.C., and Weglicki, W.B. 1980. Mechanisms of the loss of latency of lysosomal enzymes. Biochem. J. 186: 243-256.
30. Schor, N., Ichikawa, I., Rennke, H.G., Troy, J.L., and Brenner, B.M. 1981. Pathophysiology of altered glomerular function in aminoglycoside-treated rats. Kidney Int. 19: 288-296.
31. Smetana, S., Khalef, S., Nitsan, Z., Hurwitz, N., Miskin, A., Bar-Khayim, Y., and Birk, Y. 1988. Enhanced urinary trypsin inhibitory activity in gentamicin-induced nephrotoxicity in rats. Clin. Chim. Acta, 176: 333-342.
32. Smith, J.M., Balabanian, M.B., and Freeman, R.M. 1976. Serum levels of a component reacting with antiserum to urinary antitrypsin in health and disease with emphasis on high levels in renal failure. J. Lab. Clin. Med. 88: 904-913.
33. Smith, R.C., Lipsky, J.J., Laskin, O.L., Hellmann, D.B., Mellitis, E.D., Longstreth, J., and Lietman, P.S. 1980. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N. Engl. J. Med. 302: 1106-1109.
34. Umeki, S., Tsukiyama, K., Okimoto, N., and Soejima, R. 1989. Ulinastatin (Kunitz-type proteinase inhibitor) reducing cisplatin nephrotoxicity. Am. J. Med. Sci. 298: 221-226.